Lymph node status in screen-detected cancers
- PMID: 15702074
- PMCID: PMC2361727
- DOI: 10.1038/sj.bjc.6602290
Lymph node status in screen-detected cancers
Comment on
-
Screen-detected vs clinical breast cancer: the advantage in the relative risk of lymph node metastases decreases with increasing tumour size.Br J Cancer. 2005 Jan 17;92(1):156-61. doi: 10.1038/sj.bjc.6602289. Br J Cancer. 2005. PMID: 15597100 Free PMC article.
References
-
- Balslev I, Axelsson CK, Zedeler K, Rasmussen BB, Carstensen B, Mouridsen HT (1994) The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Co-operative Group (DBCG). Breast Cancer Res Treat 32: 281–290 - PubMed
-
- Bucchi L, Barchielli A, Ravaioli A, Federico M, De Lisi V, Ferretti S, Paci E, Vettorazzi M, Patriarca S, Frigerio A, Buiatti E (2005) Screen-detected vs clinical breast cancer: the advantage in relative risk of lymph node metastases decreases with increasing tumour size. Br J Cancer 92: 156–161 - PMC - PubMed
-
- Royston P, Sauerbrei W, Altman DG (2000) Modeling the effects of continuous risk factors. J Clin Epidemiol 53: 219–220 - PubMed
-
- Smith RA, Duffy SW, Gabe R, Tabar L, Yen AMF, Chen HHT (2004) The randomized trials of breast cancer screening: what have we learned? Radiol Clin N Am 42: 793–806 - PubMed
-
- Tabar L, Duffy SW, Krusemo UB (1987) Detection method, tumour size and node metastases in breast cancers diagnosed during a trial of breast cancer screening. Eur J Cancer Clin Oncol 23: 959–962 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
